Loading organizations...
§ Private Profile · Boca Raton, FL, USA
Developer of FDA-cleared wearable medical devices for continuous vital sign monitoring, enabling remote patient care for healthcare providers.
Biobeat is a Petah Tikva, Israel-based digital health company that develops wearable medical devices and an AI-powered cloud platform for continuous, non-invasive patient vital sign monitoring. The enterprise operates with a workforce of 45 employees and recently secured $50 million in Series B funding to finance its commercial expansion into the United States market. Its proprietary photoplethysmography sensors are integrated into clinical wrist monitors and chest patches, enabling healthcare providers to facilitate remote patient monitoring and home-based care programs. The company provides its hardware and SaaS solutions to major medical institutions, counting Mayo Clinic, Northwell Health Physician Partners Cardiology, and University of Miami Health among its clinical customers. The organization's corporate board of directors is currently chaired by Raymond W. Cohen. Biobeat was founded in 2012 by Arik Ben Ishay, Johanan May, and Israel Sarussi.
Biobeat has raised $50.0M across 1 funding round.
Biobeat has raised $50.0M in total across 1 funding round.
Biobeat has raised $50.0M across 1 funding round. Most recently, it raised $50.0M Series B in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 30, 2025 | $50M Series B | Steven Plachtyna, Dina Chaya, Evan Melrose | — | Announced |
Biobeat has raised $50.0M in total across 1 funding round.
Biobeat's investors include Steven Plachtyna, Dina Chaya, Evan Melrose.